• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在保护环境单元中口服抗生素预防:不可吸收和可吸收抗生素对粪便菌群的影响。

Oral antibiotic prophylaxis in protected environment units: effect of nonabsorbable and absorbable antibiotics on the fecal flora.

作者信息

Bodey G P

出版信息

Antimicrob Agents Chemother. 1972 Apr;1(4):343-7. doi: 10.1128/AAC.1.4.343.

DOI:10.1128/AAC.1.4.343
PMID:4670698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC444219/
Abstract

Eight patients in protected environment units received by the oral route a solution of gentamicin and vancomycin which completely suppressed all 78 strains of bacteria originally present in their stools. However, when the solution was discontinued bacteria were cultured again from the stools of every patient. Twenty-nine of the 42 strains cultured at this time were also cultured from pretreatment specimens. Oral absorbable antibiotics were given to six of these patients, but they eliminated only 10 of the 32 strains cultured from their stools. Seven of the 16 strains which persisted became resistant to the oral absorbable antibiotic. To achieve maximum effect, oral nonabsorbable antibiotic regimens must be continued as long as the patient remains in a protected environment unit.

摘要

在保护环境病房中的8名患者口服了庆大霉素和万古霉素溶液,该溶液完全抑制了他们粪便中原本存在的所有78株细菌。然而,当停止使用该溶液后,每个患者的粪便中又培养出了细菌。此时培养出的42株细菌中有29株也在治疗前的样本中培养出来过。其中6名患者接受了口服可吸收抗生素治疗,但他们仅清除了粪便中培养出的32株细菌中的10株。持续存在的16株细菌中有7株对口服可吸收抗生素产生了耐药性。为了达到最大效果,只要患者仍在保护环境病房中,就必须持续使用口服不可吸收抗生素方案。

相似文献

1
Oral antibiotic prophylaxis in protected environment units: effect of nonabsorbable and absorbable antibiotics on the fecal flora.在保护环境单元中口服抗生素预防:不可吸收和可吸收抗生素对粪便菌群的影响。
Antimicrob Agents Chemother. 1972 Apr;1(4):343-7. doi: 10.1128/AAC.1.4.343.
2
Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis.急性非淋巴细胞白血病的感染预防。采用层流室反向隔离并进行口服、不可吸收抗生素预防。
Ann Intern Med. 1975 Mar;82(3):351-8. doi: 10.7326/0003-4819-82-3-351.
3
Antibiotic prophylaxis in cancer patients: regimens of oral, nonabsorbable antibiotics for prevention of infection during induction of remission.癌症患者的抗生素预防:口服非吸收性抗生素预防缓解诱导期感染的方案
Rev Infect Dis. 1981 Nov-Dec;3 suppl:S259-68.
4
Total intestinal decontamination for prevention of infection in bone marrow transplantation.
Jpn J Clin Oncol. 1983;13 Suppl 1:111-26.
5
Role of vancomycin as a component of oral nonabsorbable antibiotics for microbial suppression in leukemic patients.万古霉素作为口服不吸收抗生素的一种成分在白血病患者微生物抑制中的作用。
Antimicrob Agents Chemother. 1979 Mar;15(3):455-60. doi: 10.1128/AAC.15.3.455.
6
Effect of ceftazidime and gentamicin on the oropharyngeal and faecal flora of patients with haematological malignancies.头孢他啶和庆大霉素对血液系统恶性肿瘤患者口咽及粪便菌群的影响。
J Antimicrob Chemother. 1990 Sep;26(3):419-28. doi: 10.1093/jac/26.3.419.
7
Effect of prophylactic measures on the microbial flora of patients in protected environment units.预防措施对保护环境单元中患者微生物菌群的影响。
Medicine (Baltimore). 1974 May;53(3):209-28. doi: 10.1097/00005792-197405000-00004.
8
Oropharyngeal cultures of patients in protected environment units: evaluation of semiquantitative technique during antibiotic prophylaxis.保护环境病房中患者的口咽培养:抗生素预防期间半定量技术的评估
Appl Microbiol. 1972 May;23(5):846-51. doi: 10.1128/am.23.5.846-851.1972.
9
Use of oral antibiotics in protected units environment: clinical effectiveness and role in the emergence of antibiotic-resistant strains.
Pathol Biol (Paris). 1974 Jan;22(1):5-12.
10
Oral dose and faecal concentration of antibiotics during antibiotic decontamination in mice and in a patient.小鼠及一名患者抗生素去污过程中抗生素的口服剂量及粪便浓度。
J Hyg (Lond). 1974 Oct;73(2):197-203. doi: 10.1017/s0022172400024025.

引用本文的文献

1
Increase of the intestinal absorption of gentamicin and amikacin by a nonionic surfactant.一种非离子表面活性剂对庆大霉素和阿米卡星肠道吸收的促进作用。
Antimicrob Agents Chemother. 1981 May;19(5):696-9. doi: 10.1128/AAC.19.5.696.
2
Preventing infection in neutropenic cancer patients.预防中性粒细胞减少症癌症患者的感染。
West J Med. 1983 May;138(5):690-8.
3
Effects of hepatic function on vancomycin clinical pharmacology.肝功能对万古霉素临床药理学的影响。
Antimicrob Agents Chemother. 1983 Apr;23(4):603-9. doi: 10.1128/AAC.23.4.603.
4
Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia.在粒细胞减少期间,选择性抑制消化道微生物群作为预防措施。
Antimicrob Agents Chemother. 1981 Nov;20(5):620-4. doi: 10.1128/AAC.20.5.620.
5
Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies.克霉唑(拜耳b 5097):体外及临床药理学研究。
Antimicrob Agents Chemother. 1972 Dec;2(6):423-6. doi: 10.1128/AAC.2.6.423.
6
Antibiotic-resistant bacteria in surveillance stool cultures of patients with prolonged neutropenia.长期中性粒细胞减少患者粪便监测培养中的耐抗生素细菌。
Antimicrob Agents Chemother. 1986 Sep;30(3):435-9. doi: 10.1128/AAC.30.3.435.
7
Role of vancomycin as a component of oral nonabsorbable antibiotics for microbial suppression in leukemic patients.万古霉素作为口服不吸收抗生素的一种成分在白血病患者微生物抑制中的作用。
Antimicrob Agents Chemother. 1979 Mar;15(3):455-60. doi: 10.1128/AAC.15.3.455.

本文引用的文献

1
Patient protection in cancer chemotherapy.癌症化疗中的患者保护
JAMA. 1966 Aug 22;197(8):623-7.
2
Sterile food service for patients in protected environments.为处于防护环境中的患者提供无菌餐饮服务。
J Am Diet Assoc. 1970 Jun;56(6):515-20.
3
Antibiotic susceptibility testing by a standardized single disk method.采用标准化单纸片法进行抗生素敏感性试验。
Am J Clin Pathol. 1966 Apr;45(4):493-6.
4
Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia.
Am J Med Sci. 1971 Sep;262(3):138-51. doi: 10.1097/00000441-197109000-00001.
5
Studies of patients in a laminar air flow unit.对层流空气病房中的患者进行的研究。
Cancer. 1969 Nov;24(5):972-80. doi: 10.1002/1097-0142(196911)24:5<972::aid-cncr2820240516>3.0.co;2-k.
6
Protected environment for cancer patients. Effect of a prophylactic antibiotic regimen on the microbial flora of patients undergoing cancer chemotherapy.癌症患者的保护环境。预防性抗生素方案对接受癌症化疗患者微生物菌群的影响。
Arch Intern Med. 1968 Jul;122(1):23-30. doi: 10.1001/archinte.122.1.23.
7
Microbiological evaluation of protected environments during patient occupancy.患者入住期间保护环境的微生物学评估。
Appl Microbiol. 1971 Nov;22(5):828-36. doi: 10.1128/am.22.5.828-836.1971.
8
Studiesof a patient isolator unit and prophylactic antibiotics in cancer chemotherapy. General techniques and preliminary results.癌症化疗中患者隔离单元及预防性抗生素的研究。通用技术与初步结果。
Cancer. 1968 Nov;22(5):1018-26. doi: 10.1002/1097-0142(196811)22:5<1018::aid-cncr2820220518>3.0.co;2-0.
9
Gastrointestinal "sterilization" in the treatment of patients with acute leukemia.
Cancer. 1970 Nov;26(5):1076-81. doi: 10.1002/1097-0142(197011)26:5<1076::aid-cncr2820260516>3.0.co;2-d.